XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (8,680,439) $ (7,822,039)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 276,332 250,936
Amortization of right of use asset 63,908 55,011
Write-off of capitalized patent 34,363 62,073
Write-off of fixed assets 6,211 15,371
Gain on lease termination 0 (15,319)
Stock-based compensation 997,840 1,163,808
Decrease (increase) in operating assets:    
Accounts receivable (30,808) 68,674
Inventory 31,319 21,320
Prepaid expenses and other assets 147,322 171,870
Increase (decrease) in operating liabilities:    
Accounts payable 125,082 (329,045)
Accrued expenses and other liabilities 116,535 219,483
Lease liability (60,940) (54,850)
Net cash used in operating activities (6,973,275) (6,192,707)
Cash flows from investing activities:    
Purchase of property and equipment (111,334) (193,461)
Acquisition of intangible assets (265,404) (251,639)
Net cash used in investing activities (376,738) (445,100)
Cash flows from financing activities:    
Net proceeds from issuance of common stock and pre-funded warrants 0 15,724,818
Exercise of options and warrants 110 1,105,655
Payment of taxes related to restricted stock unit vestings (98,834) (11,579)
Net cash provided by (used in) financing activities (98,724) 16,818,894
Net increase (decrease) in cash and cash equivalents (7,448,737) 10,181,087
Cash and cash equivalents at beginning of period 15,842,850 8,474,835
Cash and cash equivalents at end of period $ 8,394,113 $ 18,655,922